Dr. Zalesky is an entrepreneur in the biomedical arena. He is a founder and served as CEO and president of LumexRx, a development stage company focused on light-based therapy in gastroenterology. In that role, Dr. Zalesky raised private equity financing; recruited and managed key technical staff and consultants; directed efforts to meet the Clinical, Regulatory, Quality, and Marketing efforts of the company as well as the formulation and implementation of strategies and plans.
Dr. Zalesky holds a Bachelor of Science degree from the University of Notre Dame in Aerospace Engineering; a Master of Science degree from the University of Michigan in Aerospace Engineering; and a Ph.D. from the University of Michigan in Biomedical Engineering. He also is a co-inventor on more than 16 U.S. and international patents, encompassing intravascular ultrasound, coronary and cerebrovascular catheters and guidewires, electromechanical imaging and control systems, next-generation cardiopulmonary bypass systems, oxygen-supersaturated solutions’ preparation and vascular delivery, and photodynamic therapy devices and systems.
Dr. Zalesky has led or co-authored approximately 20 articles in medical and research journals, encompassing cardiovascular technology and devices, bench and animal model tests on new technologies for heart-related diagnosis and therapy, and clinical (patient) studies on new devices and procedures.
